Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation …

…, Y Ke, BI Gerwin, MG McMenamin, JF Lechner, RT Su… - Cancer research, 1988 - AACR
Normal human bronchial epithelial cells were infected with SV40 virus or an adenovirus 12-SV40
hybrid virus, or transfected via strontium phosphate coprecipitation with plasmids …

Supply chain costing: an activity‐based perspective

B Lin, J Collins, RK Su - … Journal of Physical Distribution & Logistics …, 2001 - emerald.com
The purpose of this research paper is to help managers improve their understanding of
logistics costs and the accounting for those costs in order to optimize use of the total cost …

In vitro replication of simian virus 40 DNA in a nucleoprotein complex.

RT Su, ML DePamphilis - Proceedings of the National …, 1976 - National Acad Sciences
A simian virus 40 (SV40) nucleoprotein complex, extracted from nuclei isolated from a monkey
cell line infected with SV40, continued DNA replication in the presence of a nuclear extract…

[HTML][HTML] Software for the frontiers of quantum chemistry: An overview of developments in the Q-Chem 5 package

…, AE Rask, A Rettig, RM Richard, F Rob… - The Journal of …, 2021 - pubs.aip.org
This article summarizes technical advances contained in the fifth major release of the Q-Chem
quantum chemistry program package, covering developments since 2015. A …

[HTML][HTML] RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

…, D Niculescu-Duvaz, N Preece, L Robert… - … England Journal of …, 2012 - Mass Medical Soc
Background Cutaneous squamous-cell carcinomas and keratoacanthomas are common
findings in patients treated with BRAF inhibitors. Methods We performed a molecular analysis to …

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 …

C Robert, A Ribas, J Schachter, A Arance… - The Lancet …, 2019 - thelancet.com
Background Pembrolizumab improved progression-free survival and overall survival versus
ipilimumab in patients with advanced melanoma and is now a standard of care in the first-…

Conversion reaction mechanisms in lithium ion batteries: study of the binary metal fluoride electrodes

F Wang, R Robert, NA Chernova… - Journal of the …, 2011 - ACS Publications
Materials that undergo a conversion reaction with lithium (eg, metal fluorides MF 2 : M = Fe,
Cu, ...) often accommodate more than one Li atom per transition-metal cation, and are …

Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance

Y Su, W Wei, L Robert, M Xue, J Tsoi… - Proceedings of the …, 2017 - National Acad Sciences
Continuous BRAF inhibition of BRAF mutant melanomas triggers a series of cell state
changes that lead to therapy resistance and escape from immune control before establishing …

Analysis of dermatologic events in vemurafenib‐treated patients with melanoma

…, M Duvic, A Hauschild, VG Prieto, C Robert… - The …, 2013 - academic.oup.com
Background. Vemurafenib has been approved for the treatment of patients with advanced
BRAF V600E ‐mutant melanoma. This report by the Vemurafenib Dermatology Working Group …

A Conventional Surfactant Becomes CO2‐Responsive in the Presence of Switchable Water Additives

X Su, T Robert, SM Mercer… - … A European Journal, 2013 - Wiley Online Library
We have developed a new benign means of reversibly breaking emulsions and latexes by
using “switchable water”, an aqueous solution of switchable ionic strength. The conventional …